Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.
Van't Hof AW, Ten Berg J, Heestermans T, Dill T, Funck RC, van Werkum W, Dambrink JH, Suryapranata H, van Houwelingen G, Ottervanger JP, Stella P, Giannitsis E, Hamm C; Ongoing Tirofiban In Myocardial infarction Evaluation (On-TIME) 2 study group. Van't Hof AW, et al. Among authors: heestermans t. Lancet. 2008 Aug 16;372(9638):537-46. doi: 10.1016/S0140-6736(08)61235-0. Lancet. 2008. PMID: 18707985 Clinical Trial.
Effect of early, pre-hospital initiation of high bolus dose tirofiban in patients with ST-segment elevation myocardial infarction on short- and long-term clinical outcome.
ten Berg JM, van 't Hof AW, Dill T, Heestermans T, van Werkum JW, Mosterd A, van Houwelingen G, Koopmans PC, Stella PR, Boersma E, Hamm C; On-TIME 2 Study Group. ten Berg JM, et al. Among authors: heestermans t. J Am Coll Cardiol. 2010 Jun 1;55(22):2446-55. doi: 10.1016/j.jacc.2009.11.091. J Am Coll Cardiol. 2010. PMID: 20510211 Free article. Clinical Trial.
Prehospital triple antiplatelet therapy in patients with acute ST elevation myocardial infarction leads to better platelet aggregation inhibition and clinical outcome than dual antiplatelet therapy.
Smit JJ, van Werkum JW, ten Berg J, Slingerland R, Ottervanger JP, Heestermans T, Dill T, Hamm C, van 't Hof AW; Ongoing Tirofiban in Myocardial Infarction Evaluation (On-TIME) trial investigators. Smit JJ, et al. Among authors: heestermans t. Heart. 2010 Nov;96(22):1815-20. doi: 10.1136/hrt.2010.201889. Epub 2010 Oct 3. Heart. 2010. PMID: 20889993 Clinical Trial.
The golden hour of prehospital reperfusion with triple antiplatelet therapy: a sub-analysis from the Ongoing Tirofiban in Myocardial Evaluation 2 (On-TIME 2) trial early initiation of triple antiplatelet therapy.
Heestermans T, van 't Hof AW, ten Berg JM, van Werkum JW, Boersma E, Mosterd A, Stella PR, van Zoelen AB, Gosselink AT, Kochman W, Dill T, Koopmans PC, van Houwelingen G, Zijlstra F, Hamm C. Heestermans T, et al. Am Heart J. 2010 Dec;160(6):1079-84. doi: 10.1016/j.ahj.2010.08.039. Am Heart J. 2010. PMID: 21146661 Clinical Trial.
Facilitated reperfusion with prehospital glycoprotein IIb/IIIa inhibition: predictors of complete ST-segment resolution before primary percutaneous coronary intervention in the On-TIME 2 trial: correlates of reperfusion before primary PCI.
Heestermans T, Suryapranata H, ten Berg JM, Mosterd A, Gosselink AT, Kochman W, Dill T, van Houwelingen G, Kolkman E, van Werkum JW, Zijlstra F, Hamm C, van 't Hof AW. Heestermans T, et al. J Electrocardiol. 2011 Jan-Feb;44(1):42-8. doi: 10.1016/j.jelectrocard.2010.09.010. J Electrocardiol. 2011. PMID: 21168000 Clinical Trial.
A clinical risk score to identify patients at high risk of very late stent thrombosis.
Godschalk TC, Gimbel ME, Nolet WW, van Kessel DJ, Amoroso G, Dewilde WJ, Wykrzykowska JJ, Janssen PW, Bergmeijer TO, Kelder JC, Heestermans T, Ten Berg JM. Godschalk TC, et al. Among authors: heestermans t. J Interv Cardiol. 2018 Apr;31(2):159-169. doi: 10.1111/joic.12494. Epub 2018 Feb 22. J Interv Cardiol. 2018. PMID: 29468725 Free article.
Coronary Angiography after Cardiac Arrest without ST-Segment Elevation.
Lemkes JS, Janssens GN, van der Hoeven NW, Jewbali LSD, Dubois EA, Meuwissen M, Rijpstra TA, Bosker HA, Blans MJ, Bleeker GB, Baak R, Vlachojannis GJ, Eikemans BJW, van der Harst P, van der Horst ICC, Voskuil M, van der Heijden JJ, Beishuizen A, Stoel M, Camaro C, van der Hoeven H, Henriques JP, Vlaar APJ, Vink MA, van den Bogaard B, Heestermans TACM, de Ruijter W, Delnoij TSR, Crijns HJGM, Jessurun GAJ, Oemrawsingh PV, Gosselink MTM, Plomp K, Magro M, Elbers PWG, van de Ven PM, Oudemans-van Straaten HM, van Royen N. Lemkes JS, et al. Among authors: heestermans tacm. N Engl J Med. 2019 Apr 11;380(15):1397-1407. doi: 10.1056/NEJMoa1816897. Epub 2019 Mar 18. N Engl J Med. 2019. PMID: 30883057 Clinical Trial.
Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial.
Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, Heestermans T, Tjon Joe Gin M, Waalewijn R, Hofma S, den Hartog F, Jukema W, von Birgelen C, Voskuil M, Kelder J, Deneer V, Ten Berg J. Gimbel M, et al. Among authors: heestermans t. Lancet. 2020 Apr 25;395(10233):1374-1381. doi: 10.1016/S0140-6736(20)30325-1. Lancet. 2020. PMID: 32334703 Clinical Trial.
32 results